461 related articles for article (PubMed ID: 21923613)
1. Intravenous immunoglobulin in the treatment of autoimmune bullous dermatoses: an update.
Czernik A; Toosi S; Bystryn JC; Grando SA
Autoimmunity; 2012 Feb; 45(1):111-8. PubMed ID: 21923613
[TBL] [Abstract][Full Text] [Related]
2. High-dose intravenous immunoglobulins for the treatment of autoimmune mucocutaneous blistering diseases: evaluation of its use in 19 cases.
Segura S; Iranzo P; Martínez-de Pablo I; Mascaró JM; Alsina M; Herrero J; Herrero C
J Am Acad Dermatol; 2007 Jun; 56(6):960-7. PubMed ID: 17368865
[TBL] [Abstract][Full Text] [Related]
3. A review of high-dose intravenous immunoglobulin (hdIVIg) in the treatment of the autoimmune blistering disorders.
Jolles S
Clin Exp Dermatol; 2001 Mar; 26(2):127-31. PubMed ID: 11298100
[TBL] [Abstract][Full Text] [Related]
4. A systematic review on efficacy, safety and treatment durability of intravenous immunoglobulin in autoimmune bullous dermatoses: Special focus on indication and combination therapy.
Kianfar N; Dasdar S; Daneshpazhooh M; Aryanian Z; Goodarzi A
Exp Dermatol; 2023 Jul; 32(7):934-944. PubMed ID: 37150538
[TBL] [Abstract][Full Text] [Related]
5. The use of intravenous immunoglobulin in autoimmune bullous diseases.
Chee SN; Murrell DF
Immunol Allergy Clin North Am; 2012 May; 32(2):323-30, viii. PubMed ID: 22560145
[TBL] [Abstract][Full Text] [Related]
6. Bullous autoimmune dermatoses.
Hofmann SC; Juratli HA; Eming R
J Dtsch Dermatol Ges; 2018 Nov; 16(11):1339-1358. PubMed ID: 30395395
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune blistering dermatoses as systemic diseases.
Vassileva S; Drenovska K; Manuelyan K
Clin Dermatol; 2014; 32(3):364-75. PubMed ID: 24767184
[TBL] [Abstract][Full Text] [Related]
8. Subepithelial autoimmune bullous dermatoses disease activity assessment and therapy.
Montagnon CM; Lehman JS; Murrell DF; Camilleri MJ; Tolkachjov SN
J Am Acad Dermatol; 2021 Jul; 85(1):18-27. PubMed ID: 33684494
[TBL] [Abstract][Full Text] [Related]
9. New immunomodulating drugs in autoimmune blistering diseases.
Korman NJ
Dermatol Clin; 2001 Oct; 19(4):637-48, viii. PubMed ID: 11705351
[TBL] [Abstract][Full Text] [Related]
10. High-dose intravenous immunoglobulin (IVIG) therapy in autoimmune skin blistering diseases.
Ishii N; Hashimoto T; Zillikens D; Ludwig RJ
Clin Rev Allergy Immunol; 2010 Apr; 38(2-3):186-95. PubMed ID: 19557317
[TBL] [Abstract][Full Text] [Related]
11. Review of autoimmune blistering diseases: the Pemphigoid diseases.
Daniel BS; Murrell DF
J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1685-1694. PubMed ID: 31087464
[TBL] [Abstract][Full Text] [Related]
12. [Bullous dermatosis--treatment up-to-date].
Komiyama E; Ikeda S
Nihon Rinsho; 2012 Mar; 70(3):509-17. PubMed ID: 22514935
[TBL] [Abstract][Full Text] [Related]
13. Subepithelial autoimmune blistering dermatoses: Clinical features and diagnosis.
Montagnon CM; Tolkachjov SN; Murrell DF; Camilleri MJ; Lehman JS
J Am Acad Dermatol; 2021 Jul; 85(1):1-14. PubMed ID: 33684496
[TBL] [Abstract][Full Text] [Related]
14. Current treatment of autoimmune blistering diseases.
Kasperkiewicz M; Schmidt E
Curr Drug Discov Technol; 2009 Dec; 6(4):270-80. PubMed ID: 20025595
[TBL] [Abstract][Full Text] [Related]
15. High-dose intravenous immunoglobulin (hdIVIg) in the treatment of autoimmune blistering disorders.
Jolles S
Clin Exp Immunol; 2002 Sep; 129(3):385-9. PubMed ID: 12197877
[No Abstract] [Full Text] [Related]
16. Rituximab in refractory autoimmune bullous diseases.
Schmidt E; Hunzelmann N; Zillikens D; Bröcker EB; Goebeler M
Clin Exp Dermatol; 2006 Jul; 31(4):503-8. PubMed ID: 16716150
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune blistering diseases in children.
Lara-Corrales I; Pope E
Semin Cutan Med Surg; 2010 Jun; 29(2):85-91. PubMed ID: 20579597
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune bullous diseases in childhood.
Sansaricq F; Stein SL; Petronic-Rosic V
Clin Dermatol; 2012; 30(1):114-27. PubMed ID: 22137235
[TBL] [Abstract][Full Text] [Related]
19. Ocular manifestations of blistering diseases.
Elchahal S; Kavosh ER; Chu DS
Immunol Allergy Clin North Am; 2008 Feb; 28(1):119-36, vii. PubMed ID: 18282549
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin: an emerging treatment for immune-mediated skin diseases.
Rütter A; Luger TA
Curr Opin Investig Drugs; 2002 May; 3(5):713-9. PubMed ID: 12090544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
